Betadine 100 mg/ml Antiseptic Paint أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

betadine 100 mg/ml antiseptic paint

mundipharma pharmaceuticals limited - iodinated povidone - cutaneous solution - 100 milligram(s)/millilitre - iodine products; povidone-iodine

Betadine Alcoholic 100 mg/ml Cutaneous Solution أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

betadine alcoholic 100 mg/ml cutaneous solution

mundipharma pharmaceuticals limited - iodinated povidone - cutaneous solution - 100 milligram(s)/millilitre - iodine products; povidone-iodine

Standardised Betadine Antiseptic 100 mg/ml Cutaneous Solution أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

standardised betadine antiseptic 100 mg/ml cutaneous solution

mundipharma pharmaceuticals limited - iodinated povidone - cutaneous solution - 100 milligram(s)/millilitre - iodine products; povidone-iodine

BRAUNODERM COLOURED أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

braunoderm coloured

b. braun medical limited - povidone-iodine isopropanol - cutaneous solution - 1 %w/v

ARK IODINE SPRAY أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

ark iodine spray

ark animal care ltd - povidone-iodine - cutaneous spray solution - 0.5 %w/v - bovine - antiseptics

Noroseal 2.6 g Intramammary Suspension for Cattle أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

noroseal 2.6 g intramammary suspension for cattle

norbrook laboratories (ireland) limited - bismuth subnitrate, heavy - intramammary suspension - 2.6 g/syringe - various products for teats and udder

Sureseal 2.6 g Intramammary Suspension for Cattle أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

sureseal 2.6 g intramammary suspension for cattle

norbrook laboratories (ireland) limited - bismuth subnitrate, heavy - intramammary suspension - 2.6 g/syringe - various products for teats and udder

Sitagliptin / Metformin hydrochloride Sun الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin.sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i.e., a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist.sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.